Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis

详细信息	查看全文 | 推荐本文 |

• 作者：Federico Lussana^a ; ^{federico.lussana@ao-sanpaolo.it} ; Michiel Coppens^b ; Marco Cattaneo^a ; Saskia Middeldorp^b
• 关键词：VTE ; venous thromboembolism ; DVT ; deep vein thrombosis ; PE ; pulmonary embolism ; FV Leiden ; factor V Leiden ; APLA ; antiphospholipid antibody ; APS ; antiphospholipid syndrome ; HIT ; heparin-induced thrombocytopenia ; UFH ; unfractionated heparin ; LMWH ; low-mole
• 刊名：Thrombosis Research
• 出版年：2012
• 期刊代码：247_00493848
• 类别：med
• 出版时间：June, 2012
• 卷：129
• 期：6
• 页码：673-680
• 文件大小：198 K

摘要

Venous thromboembolism (VTE) is a leading cause of maternal mortality and morbidity during pregnancy in developed countries. The incidence of VTE per pregnancy-year increases about 4-fold during pregnancy and at least 14-fold during the puerperium. Risk factors include a personal history of VTE, presence of inherited or acquired thrombophilia, a family history of VTE and general medical conditions, such as immobilisation, overweight, varicose veins, some haematological diseases and inflammatory disorders. VTE is considered potentially preventable with the prophylactic administration of anticoagulants, but there are no high quality randomized clinical trials that compared different strategies of thromboprophylaxis in pregnant women. Balancing the absolute risk of VTE against the risks of exposure to anticoagulants, this review provides advice regarding which women may benefit from thromboprophylaxis during and after pregnancy.